15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Definitive Healthcare Corp, 1 rate it Buy or better, 2 sit at Hold, and 2 rate it Sell or worse, a hold consensus. Targets span $0.70 to $1.00, a moderate spread. The average target of $0.85 sits 26% above the current $0.67. Sentiment has cooled somewhat, with Sell ratings rising from 1 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.04 next quarter toward $0.19 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Hold
Strong Buy00%
Buy120%
Hold240%
Sell240%
Strong Sell00%
Based on 5 analysts giving stock ratings to Definitive Healthcare Corp.
As of Jul, 1 of 5 firms rate DH a Buy (2 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
DH EPS & revenue forecast
EPS · NEXT QUARTER
$0.04
Range $0.04 – $0.05 · 7 analysts · -37% YoY
Next period, 7 analysts expect Definitive Healthcare Corp to earn $0.04 a share (range $0.04 – $0.05), versus $0.07 a year earlier. Full-year consensus is $0.18, growing to $0.19 the year after.
REVENUE · NEXT QUARTER
$55.4M
Range $54.7M – $55.8M · 7 analysts · -8% YoY
Revenue is expected to reach $55.4M (range $54.7M – $55.8M), -7.8% year-over-year. Full-year consensus is $223.4M, rising to $222.8M next year.
Top analysts covering Definitive Healthcare Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DH.
#1
Ryan MacDonald
Needham · Rank #386
Hold
No targeton DH
Overall win rate
17%
+ Follow
#2
Allen Lutz
B of A Securities
Sell
$0.70+4.0% to target
Coverage
—
+ Follow
#3
David Hynes
Canaccord Genuity
Hold
$3.00+345.7% to target
Coverage
—
+ Follow
#4
JH
Jared Haase
William Blair
Buy
No targeton DH
Coverage
—
+ Follow
#5
Saket Kalia
Barclays
Sell
$1.00+48.6% to target
Coverage
—
+ Follow
DH stock forecast FAQ
What is DH's average 12-month price target?+
The 2 analysts with a live target average $0.85 for Definitive Healthcare Corp over the next 12 months, ranging from a $1.00 high to a $0.70 low.
Is DH stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 5 analyst ratings, 1 are Buy or Strong Buy, 2 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for DH?+
The Street-high target is $1.00 (Barclays), and the Street-low is $0.70 (B of A Securities). The average of all 2 active targets is $0.85.
How many Wall Street analysts cover DH?+
5 analysts have an active rating on Definitive Healthcare Corp, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering DH?+
Among analysts who currently cover DH, Ryan MacDonald of Needham has the strongest overall Quantellect track record (Rank #386). Their current call is Hold.
What is Definitive Healthcare Corp's projected EPS for next quarter?+
The consensus estimate is $0.04 per share (range $0.04 – $0.05) across 7 analysts. Full-year EPS is projected at $0.18, rising to $0.19 the following year.
How much revenue is Definitive Healthcare Corp expected to report next quarter?+
Consensus revenue is $55.4M (range $54.7M – $55.8M). Full-year revenue is projected at $223.4M, growing to $222.8M next year.
Have analysts been upgrading or downgrading DH lately?+
As of Jul, 1 of 5 firms rate DH a Buy (2 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
